• Home
  • Media Events
  • Enhancing Diagnostic Precision: Technical Session on DxH 900 Analyzer

Enhancing Diagnostic Precision: Technical Session on DxH 900 Analyzer

Published on: August 13, 2025

The Department of Pathology at Swami Rama Himalayan University’s Himalayan Institute of Medical Sciences organized an insightful interactive technical session on the DxH 900 Hematology Analyzer on August 13, 2025. Held at the HCDRL lab on the third floor, the session brought together 58 participants, including 13 faculty members, 15 resident students, and 30 technologists from hematology and histopathology sections.

Under the guidance of Dr. Smita Chandra, Professor and Head of the Department, the session focused on the analyzer’s advanced operational features, analytical capabilities, and its clinical relevance in diagnostic hematology. The event aimed to enhance the technical proficiency of faculty, residents, and lab technologists, ensuring effective utilization of the instrument’s sophisticated functions.

The session began with a guest lecture by Meenakshi Verma and Ganesh Singh Bajeli, Senior Application Specialist at Beckman Coulter. They provided a detailed overview of the analyzer’s core technology, emphasizing innovations in impedance, flow cytometry, and algorithm-based analysis. Special attention was given to the Monocyte Distribution Width (MDW) parameter, which is gaining recognition as an early biomarker for sepsis.

A comprehensive presentation on the Internal Quality Assurance Program (IQAP) followed, highlighting key strategies such as continuous calibration, control charting, and peer data comparison to enhance result reliability. Practical guidance was offered on handling analyzer flags, minimizing downtime, and maintaining quality assurance.

In the second segment, participants engaged in interpreting scattergrams and histograms, linking graphical outputs with clinical conditions such as leukemias, infections, and anemias. Case studies from the institution’s archives were used to bridge theory with real-life application, fostering better clinical correlation.

This highly interactive session successfully reinforced the importance of technical expertise and collaborative practice in laboratory diagnostics, further aligning with the university’s commitment to excellence in patient care and medical education.

3
2
1
   Admissions Form         

Admission Open For 2025

×
International Endowed Chair Professor

Prof Rakesh Kumar

Prof Rakesh Kumar is the Founder and President of the Breast Cancer in Young Women Foundation (USA), dedicated to vaddressing the distinct issues affecting young women with breast cancer. He also serves as the International Endowed Chair Professor at the Cancer Research Institute of the Himalayan Institute of Medical Sciences. Additionally, he holds adjunct professorships at Rutgers New Jersey Medical School and Virginia Commonwealth University.

Dr Kumar earned his Ph.D. from the All India Institute of Medical Sciences in 1984 and began his research career at Memorial Sloan Kettering Cancer Center in January 1986. From 1988 to 2017, he held various academic and leadership positions —including faculty member, tenured professor, distinguished professor, endowed chair, department chair, and research leader—at esteemed institutions such as Memorial Sloan Kettering Cancer Center in New York and the University of Texas MD Anderson Cancer Center in Houston. From 2017 to 2022, he served as the National Chair for Cancer Research for the Government of India and as a distinguished professor, continuing his innovative work in breast cancer research.

With nearly 40 years of research and professional experience, Dr. Kumar has made conceptual contributions to the field of cancer research (h-index 108, citations >50,000). He has authored over 325 peer-reviewed publications, edited or co-edited nine books, and delivered 290 invited lectures worldwide. His work has been featured on the covers of 18 major cancer journals and has been highlighted in institutional research reports of the MD Anderson Cancer Center.

A passionate educator and mentor, Dr. Kumar has guided 67 trainees throughout his career. He serves on the editorial boards of multiple leading cancer journals and has served on the editorial boards of 21 top cancer journals. His global reputation is further demonstrated by his participation in about 100 peer-review panels for cancer research funding in the US and internationally over the past 28 years.

Dr. Kumar's innovative research has earned him numerous prestigious honors, including the Hinkle Society Faculty Award at Penn State University (1994), the Dalla/Fort Worth Living Legend Faculty Achievement Award in Basic Sciences (2004), the Ranbaxy Research Award (2006), and the Lifetime Achievement Award from the American Association of Indian Scientists in Cancer Research (2013), among others. Dr. Kumar's pioneering research continues to have a profound influence on the fields of oncology and breast cancer, opening up new opportunities for biomedical scientists and trainees worldwide.